CCM Zambia of the Global Fund
The Global Fund considers Zambia as one of the 20 high “impact countries” worldwide that together account for 70% of the worldwide burden of HIV/AIDS, tuberculosis and malaria and receive 70% of the value of the Global Fund grants.
Until January 2023, the Global Fund has invested in Zambia (in US$)
| Component | Signed | Disbursed |
| HIV/AIDS | 656,593,575 | 656,593,575 |
| Tuberculosis | 48,422,526 | 48,422,526 |
| HIV/TB | 710,803,557 | 504,730,986 |
| Malaria | 350,292,320 | 321,847,736 |
| Total | 1,766,111,978 | 1,531,594,823 |
In the current grant implementation phase, Zambia has nominated the Ministry of Health (MoH) and the Churches Health Association of Zambia (CHAZ) to implement the HIV/TB and malaria interventions as Principal Recipients (PR) (total value: 327,544,697 US$):
Additional US$ 80,830,854 have been granted to Zambia to address the COVID-19 pandemic.